Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [347]

Study shows why many cancer cells need to import fat

Study shows why many cancer cells need to import fat

Researchers identify cryptic vulnerabilities in an oncoprotein that could be used in the development of novel anti-cancer drugs

Researchers identify cryptic vulnerabilities in an oncoprotein that could be used in the development of novel anti...

New biomarkers unlock potential for more effective treatment of deadly cancers

New biomarkers unlock potential for more effective treatment of deadly cancers

Cancer patients receiving immunotherapy: No evidence of increased risk for severe immune complication after COVID-19 vaccination

Cancer patients receiving immunotherapy: No evidence of increased risk for severe immune complication after COVID...

Pushing T cells down “memory lane” may improve cancer therapy

Pushing T cells down “memory lane” may improve cancer therapy

Researchers discover genes that predict good response to blood cancer therapy

Researchers discover genes that predict good response to blood cancer therapy

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

EHA 2022: Transforming transfusion-dependent β-thalassemia and sickle cell disease with a single CRISPR/Cas9 gene-edited therapy

EHA 2022: Transforming transfusion-dependent β-thalassemia and sickle cell disease with a single CRISPR/Cas9 gene...

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

$ASCO 2022: High-dose ifosfamide demonstrated as a standard of care for recurrent and primary refractory ewing sarcoma$

ASCO 2022: High-dose ifosfamide demonstrated as a standard of care for recurrent and primary refractory ewing...

More from ecancer